Infectious Diseases Flashcards
Routes of Transmission
HEP B
Vertical
Horizontal
–> Sexual (very common- more infectious than HIV or HCV)
–> Blood transfusion and procedures (dialysis/ operations)
–> Needles or sharps- re-use or injury
–> Household transmission - use of shared razors or toothbrushes
Etiological agent of Hep B
enveloped DNA virus of hepadnaviridae family
Antigens of Hep B
- surface antigen (HBsAg)
- envelope antigen (HBeAg)
- core antigen
HBsAG (hep b surface antigen)
protein found in blood or serum of patients with current infection
- used as diagnostic confirmation of infection
- genetically producable –> used a vaccine
HBeAg (Envelope antigen)
allows for assessment of phase of infection
HBsAb (surface antibody)
indicates immunity to hep B following immunisation or infection
HBeAB (envelope antibody)
appears in the later phase of the disease in acute and chronic infection
evidence of immune response
HBcAb (core antibody)
found in most people exposed to HBV
- tested as total (IgG and IgM)
- doesn’t discriminate between acute/chronic/past infections
- not found after immunisation
IgM routine test on new diagnosis - identifies acute infection
HBV DNA
measured and quantified by nucleic acid testing like PCR
- determines grade of replication and activity of the virus
Acute or Chronic?
Hep B
host characteristics determines if the virus is cleared within 6 months - age, immune status
Acute hep B management
usually self limiting
no indication for treatment
occasionally fulminant hepatitis can cause liver failure (indicated by rising INR) –> requires a liver transplant
Chronic Hep B
- lasting longer than 6 months
- if acquired at birth may last decades (90% of cases chronic)
- 5% of adults with Hep B have chronic disease
Chronic Hep B
Prevention
immunisation
immunoglobulin post exposure administration
- both used in highly infectious mothers at the end of pregnancy
Hep B diagnosis
usually asymptomatic
serological testing
Chronic Hep B complications
cirrhosis
hepatocellular carcinoma
considered an oncogenic virus
Chronic Hep B management
- identifying phase of the infection
- control viral replication
- reduce inflammation
- pegylated interferon alpha (weekly injections 48/52)
- ## Tenofovir or Entecavir daily (long term)
Hep C
hepacivirus from Flaviviridae family
160,000 chronically infected in the UK
3rd largest cause of end stage liver disease
Hep C modes of transmission
- parenteral
- common in former IVDUs
- small number of pts from infected transfusions
- needle stick injuries and tattooing
- low risk of household transmission unless sharing razors or toothbrushes
- sexual transmission is rare
- vertical transmission in 6% of positive mothers
Response to infection
Hep C
- most asymptomatic or symptoms that require medical attention
- 15% - malaise, nausea, RUQ pain and jaundice
- if symptomatic more likely to clear the disease
Symptoms of Chronic Hep C
non-specific usually asymptomatic but may have: - malaise - fatigue - intermittent RUQpain
Extra-hepatic manifestations of Hep C
common associations
- essential mixed cryoglobulinaemia (abnormal proteins in blood that clump together in cold temps)
- membranoproliferative glomerulonephritis
- porphyria cutanea tarda (photosensitivity)
- autoimmune thyroid disease (women)
Extra-hepatic manifestations of Hep C
rare associations
- lichen planus
- Sjogren’s syndrome
- B-cell lymphoma
- interstitial lung disease
Diagnosis of Hep C
primarily serological
enzyme immunoassay followed by confirmatory testing with an immunoblot assay
positive serology –> HCV RNA testing with PCR to confirm current infection
HCV genotypes
6 with different geological distributions
most common in the UK are genotypes 1 & 2/3
Genotype 4 common in Africa/ Middle East
Genotype 5 common in South Africa
Genotype 6 common in SE Asia